Access cutting-edge congenital myasthenic syndrome treatment through this clinical trial at a research site in Sacramento. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Sacramento location
Preparing your pre-screening questions…
Access congenital myasthenic syndrome specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related congenital myasthenic syndrome treatment provided free
Check if you qualify for this congenital myasthenic syndrome clinical trial in Sacramento, CA
No-Cost Study Care
Local to Sacramento
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to assess the safety and tolerability of ARGX-119 in adult participants with DOK7- Congenital Myasthenic Syndromes. The study will also assess how ARGX-119 is processed by the body (pharmacokinetics), how the immune system reacts to it (immunogenicity), and how it may improve the way patients feel and function. After the screening period, eligible participants will be randomized in a 4:1 ratio to receive intravenous infusions of ARGX-119 or placebo during the double-blinded treatment period. Participants will then enter the follow-up period. After the follow-up period, participants may enrol in the active-treatment period, where they will receive open-label ARGX-119. The full duration of the study is approximately 38 months.
Sponsor: argenx
Yes, this clinical trial (NCT06436742) has an active research site in Sacramento, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for congenital myasthenic syndrome treatment options in Sacramento, CA, this clinical trial (NCT06436742) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sacramento research site is actively enrolling participants for this clinical trial. You'll receive care from experienced congenital myasthenic syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all congenital myasthenic syndrome clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in Sacramento — not just this study.
Browse Ankylosing Spondylitis Trials in Sacramento →